A novel microfluidic device capable of maintaining functional thyroid carcinoma specimens ex vivo provides a new drug screening platform

BACKGROUND: Though the management of malignancies has improved vastly in recent years, many treatment options lack the desired efficacy and fail to adequately augment patient morbidity and mortality. It is increasingly clear that patient response to therapy is unique to each individual, necessitatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Riley, Andrew, Green, Victoria, Cheah, Ramsah, McKenzie, Gordon, Karsai, Laszlo, England, James, Greenman, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429713/
https://www.ncbi.nlm.nih.gov/pubmed/30902086
http://dx.doi.org/10.1186/s12885-019-5465-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429713/
https://www.ncbi.nlm.nih.gov/pubmed/30902086
http://dx.doi.org/10.1186/s12885-019-5465-z

Ejemplares similares